CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 379 enrolled
Drug / intervention
Thermocoagulationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04191967
NCT04191967N/ACompleted
CompareCT.gov

Cervical Cancer Screening Among HIV-infected Women in Western Kenya: Evaluation of the Safety, Acceptability, and Efficacy of an Alternative Ablation Method for Treatment of Precancerous Lesions

University of California, San Francisco·interventional·Posted Dec 10, 2019·Updated Jan 25, 2023

In Brief

A clinical study evaluating Thermocoagulation for Human Immunodeficiency Virus and 2 related conditions. Completed, enrolled 379 participants across 1 site.

Detailed Summary

The purpose of this study is to evaluate the safety, acceptability, and efficacy of Thermocoagulation for treatment of precancerous lesions among HIV-positive women in a screen-and-treat program in Western Kenya.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHuman Immunodeficiency Virus, HPV Infection, CIN 2/3
CountriesKenya
CollaboratorsNational Institutes of Health (NIH), Fogarty International Center of the National Institute of Health

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedDec 10, 2019
Enrollment StartSep 25, 2019
Primary CompletionNov 30, 2021
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 6.6 years ago

Interventions

Thermocoagulationdevice

Treatment of positive screening results will be performed using the Liger Thermocoagulator device